Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trinity Biotech (TRIB) EPS (Basic) (2016 - 2024)

Trinity Biotech's EPS (Basic) history spans 16 years, with the latest figure at -$0.04 for Q4 2024.

  • On a quarterly basis, EPS (Basic) fell 24.92% to -$0.04 in Q4 2024 year-over-year; TTM through Dec 2025 was -$0.05, a 8.57% increase, with the full-year FY2025 number at -$0.1, changed 0.0% from a year prior.
  • EPS (Basic) hit -$0.04 in Q4 2024 for Trinity Biotech, down from -$0.0 in the prior quarter.
  • Over the last five years, EPS (Basic) for TRIB hit a ceiling of $0.12 in Q4 2020 and a floor of -$0.08 in Q4 2022.
  • Historically, EPS (Basic) has averaged -$0.0 across 5 years, with a median of -$0.0 in 2024.
  • Biggest five-year swings in EPS (Basic): skyrocketed 511.27% in 2020 and later crashed 187828.82% in 2023.
  • Tracing TRIB's EPS (Basic) over 5 years: stood at $0.12 in 2020, then tumbled by 132.48% to -$0.04 in 2021, then plummeted by 92.27% to -$0.08 in 2022, then surged by 54.5% to -$0.04 in 2023, then dropped by 24.92% to -$0.04 in 2024.
  • Business Quant data shows EPS (Basic) for TRIB at -$0.04 in Q4 2024, -$0.0 in Q3 2024, and -$0.0 in Q2 2024.